TNK2 and non-small cell lung carcinoma: For researching the role of ACK1-associated immunomodulators in non-small cell lung cancer (NSCLC), Zhu J et al. Established a multiple-gene risk prediction model, and the results showed the risk scores were an independent prognosis predictor in the TCGA lung cohorts72.